Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 9
2001 21
2002 26
2003 35
2004 54
2005 55
2006 42
2007 66
2008 50
2009 69
2010 72
2011 74
2012 85
2013 76
2014 83
2015 88
2016 83
2017 75
2018 76
2019 82
2020 106
2021 110
2022 149
2023 155
2024 105
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,672 results

Results by year

Filters applied: Free full text. Clear all
Page 1
Results of a Prospective Randomized Multicenter Study Comparing Indocyanine Green (ICG) Fluorescence Combined with a Standard Tracer Versus ICG Alone for Sentinel Lymph Node Biopsy in Early Breast Cancer: The INFLUENCE Trial.
Pitsinis V, Kanitkar R, Vinci A, Choong WL, Benson J. Pitsinis V, et al. Ann Surg Oncol. 2024 Dec;31(13):8848-8855. doi: 10.1245/s10434-024-16176-x. Epub 2024 Sep 12. Ann Surg Oncol. 2024. PMID: 39266795 Free PMC article. Clinical Trial.
Single pre-operative radiation therapy (SPORT-CK) trial for low-risk breast cancer: Early results of a phase 2 study.
Mahmoud D, Yassa M, Alvarado L, Lambert C, Meterissian S, Anderson D, Tremblay F, Otaky N, Keyserlingk J, Panet-Raymond V, Kopek N, David M, Duclos M, Pembroke C, Fleiszer D, Meguerditchian AN, Loutfi A, Lavigne D, Hijal T. Mahmoud D, et al. Radiother Oncol. 2024 Nov;200:110510. doi: 10.1016/j.radonc.2024.110510. Epub 2024 Aug 30. Radiother Oncol. 2024. PMID: 39218040 Free article. Clinical Trial.
Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy.
Muslumanoglu M, Mollavelioglu B, Cabioglu N, Emiroglu S, Tukenmez M, Karanlık H, Ozmen T, Yılmaz R, Comert RG, Onder S, Bayram A, Simsek DH, Oflas M, Ibis K, Aydıner A, Ozmen V, Igci A. Muslumanoglu M, et al. World J Surg Oncol. 2024 Oct 31;22(1):286. doi: 10.1186/s12957-024-03547-7. World J Surg Oncol. 2024. PMID: 39478502 Free PMC article.
Radiological and pathological predictors of post-operative upstaging of breast ductal carcinoma in situ (DCIS) to invasive ductal carcinoma and lymph-nodes metastasis; a potential algorithm for node surgical de-escalation.
Vanni G, Pellicciaro M, Materazzo M, Berretta M, Meucci R, Perretta T, Portarena I, Pistolese CA, Buonomo OC. Vanni G, et al. Surg Oncol. 2024 Oct;56:102128. doi: 10.1016/j.suronc.2024.102128. Epub 2024 Aug 30. Surg Oncol. 2024. PMID: 39241490 Free article.
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA. Switalla KM, et al. Ann Surg Oncol. 2024 Oct;31(11):7249-7259. doi: 10.1245/s10434-024-15792-x. Epub 2024 Jul 12. Ann Surg Oncol. 2024. PMID: 38995451 Free PMC article.
Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancer.
van Amstel FJG, de Mooij CM, Simons JM, Mitea C, van Diest PJ, Nelemans PJ, van der Pol CC, Luiten EJT, Koppert LB, Smidt ML, van Nijnatten TJA; REFINE Study Group. van Amstel FJG, et al. Br J Surg. 2024 Aug 30;111(9):znae203. doi: 10.1093/bjs/znae203. Br J Surg. 2024. PMID: 39302345 Free PMC article. Clinical Trial.
Comparison of Indocyanine Green with conventional tracers for sentinel lymph node biopsy in breast cancer: A multidisciplinary evaluation of clinical effectiveness, safety, organizational and economic impact.
Pinelli M, Gerardi C, Lettieri E, Maioru M, Marone L, Bertoldi L, Navanteri G, Costantini M, Botti C, Pellini F. Pinelli M, et al. PLoS One. 2024 Aug 29;19(8):e0309336. doi: 10.1371/journal.pone.0309336. eCollection 2024. PLoS One. 2024. PMID: 39208241 Free PMC article.
Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial.
van Dooijeweert C, Flach RN, Ter Hoeve ND, Vreuls CPH, Goldschmeding R, Freund JE, Pham P, Nguyen TQ, van der Wall E, Frederix GWJ, Stathonikos N, van Diest PJ. van Dooijeweert C, et al. Nat Cancer. 2024 Aug;5(8):1195-1205. doi: 10.1038/s43018-024-00788-z. Epub 2024 Jun 27. Nat Cancer. 2024. PMID: 38937624 Free PMC article. Clinical Trial.
The features of male breast cancer in China: A real-world study.
Gao Y, Zhang M, Sun G, Ma L, Nie J, Yuan Z, Liu Z, Cao Y, Li J, Liu Q, Ye S, Chen B, Song Y, Wang K, Ren Y, Ye G, Xu L, Liu S, Chen Q, Li W, Chen X, Fu P, Wei W, Guo B, Wang H, Cai Z, Du C, Wu Z, Zha X, Huang H, Xu J, Zhang C, Shi Y, Liu T, Liu S, Jiang Z, Lin Y. Gao Y, et al. Breast. 2024 Aug;76:103762. doi: 10.1016/j.breast.2024.103762. Epub 2024 Jun 22. Breast. 2024. PMID: 38924994 Free PMC article.
Quality assessment of radiotherapy in the prospective randomized SENOMAC trial.
Alkner S, Wieslander E, Lundstedt D, Berg M, Kristensen I, Andersson Y, Bergkvist L, Frisell J, Olofsson Bagge R, Sund M, Christiansen P, Davide Gentilini O, Kontos M, Kühn T, Reimer T, Rydén L, Filtenborg Tvedskov T, Vrou Offersen B, Dahl Nissen H, de Boniface J; SENOMAC Trialists’ Group. Alkner S, et al. Radiother Oncol. 2024 Aug;197:110372. doi: 10.1016/j.radonc.2024.110372. Epub 2024 Jun 10. Radiother Oncol. 2024. PMID: 38866204 Free article. Clinical Trial.
Artificial Intelligence Helps Pathologists Increase Diagnostic Accuracy and Efficiency in the Detection of Breast Cancer Lymph Node Metastases.
Retamero JA, Gulturk E, Bozkurt A, Liu S, Gorgan M, Moral L, Horton M, Parke A, Malfroid K, Sue J, Rothrock B, Oakley G, DeMuth G, Millar E, Fuchs TJ, Klimstra DS. Retamero JA, et al. Am J Surg Pathol. 2024 Jul 1;48(7):846-854. doi: 10.1097/PAS.0000000000002248. Epub 2024 May 27. Am J Surg Pathol. 2024. PMID: 38809272 Free PMC article.
Axillary Management: How Much Is Too Much?
Owusu-Brackett N, Facer B, Quiroga D, Pariser A, Grimm M, Beyer S, Jhawar S, Oppong BA. Owusu-Brackett N, et al. Curr Oncol Rep. 2024 Jul;26(7):735-743. doi: 10.1007/s11912-024-01539-0. Epub 2024 May 15. Curr Oncol Rep. 2024. PMID: 38748364 Free PMC article. Review.
Sentinel lymph node biopsy before and after neoadjuvant chemotherapy in cN0 breast cancer patients: impact on axillary morbidity and survival-a propensity score cohort study.
Fernandez-Gonzalez S, Falo C, Pla MJ, Campos M, Ortega-Exposito C, Ortega R, Vicente M, Petit A, Bosch-Schips J, Bajen MT, Reyes G, Martínez E, González-Viguera J, Peñafiel J, Stradella A, Pernas S, Ponce J, Garcia-Tejedor A. Fernandez-Gonzalez S, et al. Breast Cancer Res Treat. 2024 Jul;206(1):131-141. doi: 10.1007/s10549-024-07274-1. Epub 2024 Apr 18. Breast Cancer Res Treat. 2024. PMID: 38635082 Free PMC article.
Electrical lymph node scanning (ELS) system for real-time intra-operative detection of involved axillary lymph nodes in adjuvant breast cancer patients.
Abbasvandi F, Mahdavi R, Bayat M, Hajighasemi F, Jahanbakhshi F, Aghaei F, Sami N, Khoundabi B, Ataee H, Yousefpour N, Hoseinpour P, Mousavi Kiasary SMS, Omrani Hashemi M, Shojaeian F, Akbari A, Bagherhosseini N, Moradi A, Akbari ME, Abdolahad M. Abbasvandi F, et al. Sci Rep. 2024 Jun 5;14(1):12900. doi: 10.1038/s41598-024-61600-7. Sci Rep. 2024. PMID: 38839807 Free PMC article.
Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay.
Bernet-Vegué L, Cantero-González C, Sancho de Salas M, Parada D, Perin T, Quintero-Niño Z, Vieites Pérez-Quintela B, Sánchez-Guzmán D, Castelvetere M, Hardisson Hernaez D, Martín-Salvago MD. Bernet-Vegué L, et al. Clin Transl Oncol. 2024 May;26(5):1220-1228. doi: 10.1007/s12094-023-03347-7. Epub 2023 Dec 9. Clin Transl Oncol. 2024. PMID: 38070048 Free PMC article.
De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07).
de Wild SR, van Roozendaal LM, de Wilt JHW, van Dalen T, van der Hage JA, van Duijnhoven FH, Simons JM, Schipper RJ, de Munck L, van Kuijk SMJ, Boersma LJ, Linn SC, Lobbes MBI, Poortmans PMP, Tjan-Heijnen VCG, van de Vijver KKBT, de Vries J, Westenberg AH, Strobbe LJA, Smidt ML. de Wild SR, et al. Br J Surg. 2024 Apr 3;111(4):znae077. doi: 10.1093/bjs/znae077. Br J Surg. 2024. PMID: 38597154 Free PMC article.
Indocyanine green fluorescence versus blue dye, technetium-99M, and the dual-marker combination of technetium-99M + blue dye for sentinel lymph node detection in early breast cancer-meta-analysis including consistency analysis.
White KP, Sinagra D, Dip F, Rosenthal RJ, Mueller EA, Lo Menzo E, Rancati A. White KP, et al. Surgery. 2024 Apr;175(4):963-973. doi: 10.1016/j.surg.2023.10.021. Epub 2023 Dec 13. Surgery. 2024. PMID: 38097484 Free article. Review.
Surgical treatment of breast cancer.
Tvedskov TF, Lautrup MD, Kroman NT, Christiansen PM. Tvedskov TF, et al. Ugeskr Laeger. 2024 Mar 18;186(12):V01230033. doi: 10.61409/V01230033. Ugeskr Laeger. 2024. PMID: 38533870 Free article. Review. Danish.
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?
Guo X, Zhang J, Gong X, Wang J, Dai H, Jiao D, Ling R, Zhao Y, Yang H, Liu Y, Liu K, Zhang J, Mao D, He J, Yu Z, Liu Y, Fu P, Wang J, Jiang H, Zhao Z, Tian X, Cao Z, Wu K, Song A, Jin F, Fan Z, Liu Z. Guo X, et al. Breast. 2024 Feb;73:103671. doi: 10.1016/j.breast.2024.103671. Epub 2024 Jan 5. Breast. 2024. PMID: 38277714 Free PMC article.
Is routine axillary lymph node dissection needed to tailor systemic treatments for breast cancer patients in the era of molecular oncology? A position paper of the Italian National Association of Breast Surgeons (ANISC).
Rocco N, Ghilli M, Curcio A, Bortul M, Burlizzi S, Cabula C, Cabula R, Ferrari A, Folli S, Fortunato L, Frittelli P, Gentilini O, Grendele S, Grassi MM, Grossi S, Magnoni F, Murgo R, Palli D, Rovera F, Sanguinetti A, Taffurelli M, Tazzioli G, Terribile DA, Caruso F, Galimberti V. Rocco N, et al. Eur J Surg Oncol. 2024 Feb;50(2):107954. doi: 10.1016/j.ejso.2024.107954. Epub 2024 Jan 6. Eur J Surg Oncol. 2024. PMID: 38217946 Free article. Review.
Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial.
Wintraecken VM, Boersma LJ, van Roozendaal LM, de Vries J, van Kuijk SMJ, Vane MLG, van Dalen T, van der Hage JA, Strobbe LJA, Linn SC, Lobbes MBI, Poortmans PMP, Tjan-Heijnen VCG, van de Vijver KKBT, Westenberg AH, de Wilt JHW, Smidt ML, Simons JM; BOOG 2013-08 group. Wintraecken VM, et al. Radiother Oncol. 2024 Feb;191:110069. doi: 10.1016/j.radonc.2023.110069. Epub 2023 Dec 21. Radiother Oncol. 2024. PMID: 38141879 Free article. Clinical Trial.
Reliability of predicting low-burden (≤ 2) positive axillary lymph nodes indicating sentinel lymph node biopsy in primary operable breast cancer - a retrospective comparative study with PET/CT and breast MRI.
Sae-Lim C, Wu WP, Chang MC, Lai HW, Chen ST, Chou CT, Liao CY, Huang HI, Chen ST, Chen DR, Hung CL. Sae-Lim C, et al. World J Surg Oncol. 2024 Jan 6;22(1):12. doi: 10.1186/s12957-023-03297-y. World J Surg Oncol. 2024. PMID: 38183069 Free PMC article.
Nodal positivity in patients with clinically and radiologically node-negative breast cancer treated with neoadjuvant chemotherapy: multicentre collaborative study.
Zaborowski AM, Doogan K, Clifford S, Dowling G, Kazi F, Delaney K, Yadav H, Brady A, Geraghty J, Evoy D, Rothwell J, McCartan D, Heeney A, Barry M, Walsh SM, Stokes M, Kell MR, Allen M, Power C, Hill ADK, Connolly E, Alazawi D, Boyle T, Corrigan M, O'Leary P, Prichard RS. Zaborowski AM, et al. Br J Surg. 2024 Jan 3;111(1):znad401. doi: 10.1093/bjs/znad401. Br J Surg. 2024. PMID: 38055888 Free PMC article.
Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
Weber WP, Heidinger M, Hayoz S, Matrai Z, Tausch C, Henke G, Zwahlen DR, Gruber G, Zimmermann F, Montagna G, Andreozzi M, Goldschmidt M, Schulz A, Mueller A, Ackerknecht M, Tampaki EC, Bjelic-Radisic V, Kurzeder C, Sávolt Á, Smanykó V, Hagen D, Müller DJ, Gnant M, Loibl S, Fitzal F, Markellou P, Bekes I, Egle D, Heil J, Knauer M. Weber WP, et al. Ann Surg Oncol. 2024 Jan;31(1):344-355. doi: 10.1245/s10434-023-14404-4. Epub 2023 Oct 30. Ann Surg Oncol. 2024. PMID: 37903951 Free PMC article. Clinical Trial.
Gene expression profiles in clinically T1-2N0 ER+HER2- breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed.
van Roozendaal LM, Vane MLG, Colier E, Strobbe LJA, de Boer M, Sonke G, Van Maaren MC, Smidt ML. van Roozendaal LM, et al. Breast Cancer Res Treat. 2024 Jan;203(1):103-110. doi: 10.1007/s10549-023-07128-2. Epub 2023 Oct 5. Breast Cancer Res Treat. 2024. PMID: 37794289 Free PMC article.
Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological images.
Marmé F, Krieghoff-Henning E, Gerber B, Schmitt M, Zahm DM, Bauerschlag D, Forstbauer H, Hildebrandt G, Ataseven B, Brodkorb T, Denkert C, Stachs A, Krug D, Heil J, Golatta M, Kühn T, Nekljudova V, Gaiser T, Schönmehl R, Brochhausen C, Loibl S, Reimer T, Brinker TJ. Marmé F, et al. Eur J Cancer. 2023 Dec;195:113390. doi: 10.1016/j.ejca.2023.113390. Epub 2023 Oct 18. Eur J Cancer. 2023. PMID: 37890350 Free article.
New Alternative Techniques for Sentinel Lymph Node Biopsy.
Subramonian S, Chopra S, Vidya R. Subramonian S, et al. Medicina (Kaunas). 2023 Nov 26;59(12):2077. doi: 10.3390/medicina59122077. Medicina (Kaunas). 2023. PMID: 38138180 Free PMC article. Review.
Telepathology in intraoperative frozen section consultation of breast cancer sentinel node biopsy in Fukushima, Japan following the 2011 triple disaster: diagnostic accuracy and required time during the early implementation phase.
Kawakami H, Ozaki A, Kaneda Y, Asano S, Inai K, Hirooka S, Katoono A, Takagi R, Kosaka M, Murayama A, Sawano T, Shimamura Y, Tsubokura M, Kurokawa T, Tachibana K, Wada M, Tanimoto T, Ohtake T, Kitamura N, Ejiri T, Magome H, Shimmura H, Kanzaki N. Kawakami H, et al. Rural Remote Health. 2023 Nov;23(4):8496. doi: 10.22605/RRH8496. Epub 2023 Nov 7. Rural Remote Health. 2023. PMID: 37933099 Free article.
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M, Agresti R, Luini A, Viale G, Cassano E, Peradze N, Toesca A, Massari G, Sacchini V, Munzone E, Leonardi MC, Cattadori F, Di Micco R, Esposito E, Sgarella A, Cattaneo S, Busani M, Dessena M, Bianchi A, Cretella E, Ripoll Orts F, Mueller M, Tinterri C, Chahuan Manzur BJ, Benedetto C, Veronesi P; SOUND Trial Group. Gentilini OD, et al. JAMA Oncol. 2023 Nov 1;9(11):1557-1564. doi: 10.1001/jamaoncol.2023.3759. JAMA Oncol. 2023. PMID: 37733364 Free PMC article.
Diagnostic accuracy of pre-operative breast magnetic resonance imaging (MRI) in predicting axillary lymph node metastasis: variations in intrinsic subtypes, and strategy to improve negative predictive value-an analysis of 2473 invasive breast cancer patients.
Chen ST, Lai HW, Chang JH, Liao CY, Wen TC, Wu WP, Wu HK, Lin YJ, Chang YJ, Chen ST, Chen DR, Huang HI, Hung CL. Chen ST, et al. Breast Cancer. 2023 Nov;30(6):976-985. doi: 10.1007/s12282-023-01488-9. Epub 2023 Jul 27. Breast Cancer. 2023. PMID: 37500823 Free PMC article.
Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients.
van Haaren ERM, Poodt IGM, Spiekerman van Weezelenburg MA, van Bastelaar J, Janssen A, de Vries B, Lobbes MBI, Bouwman LH, Vissers YLJ. van Haaren ERM, et al. Breast Cancer Res Treat. 2023 Nov;202(2):245-255. doi: 10.1007/s10549-023-07065-0. Epub 2023 Jul 27. Breast Cancer Res Treat. 2023. PMID: 37495799 Free PMC article.
ASO Author Reflections: Objective Outcome Measure of Upper Limb Function Following Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy.
Che Bakri NA, Kwasnicki RM, Giannas E, Tenang L, Khan N, Moenig C, Imam Z, Dhillon K, Ashrafian H, Darzi A, Leff DR. Che Bakri NA, et al. Ann Surg Oncol. 2023 Nov;30(12):7133-7134. doi: 10.1245/s10434-023-13984-5. Epub 2023 Jul 23. Ann Surg Oncol. 2023. PMID: 37482598 Free PMC article. No abstract available.
Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer.
Weber WP, Matrai Z, Hayoz S, Tausch C, Henke G, Zimmermann F, Montagna G, Fitzal F, Gnant M, Ruhstaller T, Muenst S, Mueller A, Lelièvre L, Heil J, Knauer M, Egle D, Sávolt Á, Heidinger M, Kurzeder C; TAXIS Study Writing Group; Zwahlen DR, Gruber G, Ackerknecht M, Kuemmel S, Bjelic-Radisic V, Smanykó V, Vrieling C, Satler R, Hagen D, Becciolini C, Bucher S, Simonson C, Fehr PM, Gabriel N, Maráz R, Sarlos D, Dedes KJ, Leo C, Berclaz G, Fansa H, Hager C, Reisenberger K, Singer CF, Loibl S, Winkler J, Lam GT, Fehr MK, Kohlik M, Clerc K, Ostapenko V, Maggi N, Schulz A, Andreozzi M, Goldschmidt M, Saccilotto R, Markellou P. Weber WP, et al. JAMA Surg. 2023 Oct 1;158(10):1013-1021. doi: 10.1001/jamasurg.2023.2840. JAMA Surg. 2023. PMID: 37466971 Free PMC article. Clinical Trial.
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Tinterri C, Canavese G, Gatzemeier W, Barbieri E, Bottini A, Sagona A, Caraceni G, Testori A, Di Maria Grimaldi S, Dani C, Boni L, Bruzzi P, Fernandes B, Scorsetti M, Zambelli A, Gentile D; SINODAR-ONE Collaborative Group. Tinterri C, et al. Br J Surg. 2023 Aug 11;110(9):1143-1152. doi: 10.1093/bjs/znad215. Br J Surg. 2023. PMID: 37471574 Free PMC article. Clinical Trial.
Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer.
Kuemmel S, Heil J, Bruzas S, Breit E, Schindowski D, Harrach H, Chiari O, Hellerhoff K, Bensmann E, Hanf V, Graßhoff ST, Deuschle P, Belke K, Polata S, Paepke S, Warm M, Meiler J, Schindlbeck C, Ruhwedel W, Beckmann U, Groh U, Dall P, Blohmer JU, Traut A, Reinisch M. Kuemmel S, et al. JAMA Surg. 2023 Aug 1;158(8):807-815. doi: 10.1001/jamasurg.2023.1772. JAMA Surg. 2023. PMID: 37285140 Free PMC article.
The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer.
Aristei C, Kaidar-Person O, Boersma L, Leonardi MC, Offersen B, Franco P, Arenas M, Bourgier C, Pfeffer R, Kouloulias V, Bölükbaşı Y, Meattini I, Coles C, Luis AM, Masiello V, Palumbo I, Morganti AG, Perrucci E, Tombolini V, Krengli M, Marazzi F, Trigo L, Borghesi S, Ciabattoni A, Ratoša I, Valentini V, Poortmans P. Aristei C, et al. Crit Rev Oncol Hematol. 2023 Jul;187:104035. doi: 10.1016/j.critrevonc.2023.104035. Epub 2023 May 26. Crit Rev Oncol Hematol. 2023. PMID: 37244324 Free article. Review.
Value of total tumor load as a clinical and pathological factor in the prognosis of breast cancer patients receiving neoadjuvant treatment. Comparison of three populations with three different surgical approaches: NEOVATTL Pro 3 Study.
Martín-Salvago MD, Sancho M, López-García MÁ, Cano Jiménez A, Pérez-Luque A, Alfaro L, Vieites B. Martín-Salvago MD, et al. Breast Cancer Res Treat. 2023 Jul;200(2):203-215. doi: 10.1007/s10549-023-06954-8. Epub 2023 May 23. Breast Cancer Res Treat. 2023. PMID: 37219637 Free PMC article.
Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study.
Karakatsanis A, Eriksson S, Pistiolis L, Olofsson Bagge R, Nagy G, Man V, Kwong A, Wärnberg F; SentiNot Trialists Group. Karakatsanis A, et al. Ann Surg Oncol. 2023 Jul;30(7):4064-4072. doi: 10.1245/s10434-022-13064-0. Epub 2023 Jan 31. Ann Surg Oncol. 2023. PMID: 36719570 Free PMC article.
Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohorts.
Weiss A, Martínez-Sáez O, Waks AG, Laws A, McGrath M, Tarantino P, Portnow L, Winer E, Rey M, Tapia M, Prat A, Partridge AH, Tolaney SM, Cejalvo JM, Mittendorf EA, King TA. Weiss A, et al. Cancer. 2023 Jun 15;129(12):1836-1845. doi: 10.1002/cncr.34750. Epub 2023 Mar 23. Cancer. 2023. PMID: 36951169 Free article.
Uncertainties and controversies in axillary management of patients with breast cancer.
Weber WP, Davide Gentilini O, Morrow M, Montagna G, de Boniface J, Fitzal F, Wyld L, Rubio IT, Matrai Z, King TA, Saccilotto R, Galimberti V, Maggi N, Andreozzi M, Sacchini V, Castrezana López L, Loesch J, Schwab FD, Eller R, Heidinger M, Haug M, Kurzeder C, Di Micco R, Banys-Paluchowski M, Ditsch N, Harder Y, Paulinelli RR, Urban C, Benson J, Bjelic-Radisic V, Potter S, Knauer M, Thill M, Vrancken Peeters MJ, Kuemmel S, Heil J, Gulluoglu BM, Tausch C, Ganz-Blaettler U, Shaw J, Dubsky P, Poortmans P, Kaidar-Person O, Kühn T, Gnant M. Weber WP, et al. Cancer Treat Rev. 2023 Jun;117:102556. doi: 10.1016/j.ctrv.2023.102556. Epub 2023 Apr 23. Cancer Treat Rev. 2023. PMID: 37126938 Free PMC article. Review.
Real de-escalation or escalation in disguise?
Banys-Paluchowski M, Rubio IT, Ditsch N, Krug D, Gentilini OD, Kühn T. Banys-Paluchowski M, et al. Breast. 2023 Jun;69:249-257. doi: 10.1016/j.breast.2023.03.001. Epub 2023 Mar 4. Breast. 2023. PMID: 36898258 Free PMC article.
Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey.
Banys-Paluchowski M, Untch M, Krawczyk N, Thurmann M, Kühn T, Sehouli J, Gasparri ML, de Boniface J, Gentilini OD, Stickeler E, Ditsch N, Rody A, Paluchowski P, Blohmer JU. Banys-Paluchowski M, et al. Arch Gynecol Obstet. 2023 May;307(5):1547-1556. doi: 10.1007/s00404-022-06804-w. Epub 2022 Oct 10. Arch Gynecol Obstet. 2023. PMID: 36214890 Free PMC article.
1,672 results